Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine


The loss of vision after damage to the retina, optic nerve, or brain has often grave consequences in everyday life such as problems with recognizing faces, reading, or mobility. Because vision loss is considered to be irreversible and often progressive, patients experience continuous mental stress due to worries, anxiety, or fear with secondary consequences such as depression and social isolation. While prolonged mental stress is clearly a consequence of vision loss, it may also aggravate the situation. In fact, continuous stress and elevated cortisol levels negatively impact the eye and brain due to autonomous nervous system (sympathetic) imbalance and vascular dysregulation; hence stress may also be one of the major causes of visual system diseases such as glaucoma and optic neuropathy. Although stress is a known risk factor, its causal role in the development or progression of certain visual system disorders is not widely appreciated. This review of the literature discusses the relationship of stress and ophthalmological diseases. We conclude that stress is both consequence and cause of vision loss. This creates a vicious cycle of a downward spiral, in which initial vision loss creates stress which further accelerates vision loss, creating even more stress and so forth. This new psychosomatic perspective has several implications for clinical practice. Firstly, stress reduction and relaxation techniques (e.g., meditation, autogenic training, stress management training, and psychotherapy to learn to cope) should be recommended not only as complementary to traditional treatments of vision loss but possibly as preventive means to reduce progression of vision loss. Secondly, doctors should try their best to inculcate positivity and optimism in their patients while giving them the information the patients are entitled to, especially regarding the important value of stress reduction. In this way, the vicious cycle could be interrupted. More clinical studies are now needed to confirm the causal role of stress in different low vision diseases to evaluate the efficacy of different anti-stress therapies for preventing progression and improving vision recovery and restoration in randomized trials as a foundation of psychosomatic ophthalmology.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. 1.

    WHO. Visual impairment and blindness. 2014.

  2. 2.

    Kempen GIJM, Ballemans J, Ranchor AV, et al. The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living oder adults seeking vision rehabilitation services. Qual Life Res. 2012;21:1405–11.

    PubMed  Article  Google Scholar 

  3. 3.

    Sabel BA, Fedorov A, Henrich-Noack P, Gall C. Vision restoration after brain damage: the “residual vision activation theory”. Prog Brain Res. 2010;192:199–262.

    Article  Google Scholar 

  4. 4.

    Kasten E, Wüst S, Behrens-Baumann W, et al. Computer-based training for the treatment of partial blindness. Nat Med. 1998;4:1083–7.

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Sabel BA, Gudlin J. Vision restoration training for Glaucoma. A randomized clinical trial. JAMA Ophthalmology. 2014;132:381–9.

    PubMed  Article  Google Scholar 

  6. 6.

    Fedorov A, Jobke S, Bersnev V, Chibisova A, Chibisova Y, Gall C, et al. Restoration of vision after optic nerve lesions with noninvasive transorbital alternating current stimulation: a clinical observation study. Brain Stimul. 2011;4:189–201.

  7. 7.

    Gall C, Sgorzaly S, Schmidt S, Brandt S, Fedorov A, Sabel BA. Noninvasive transorbital alternating current stimulation improves subjective visual functioning and vision-related quality of life in optic neuropathy. Brain Stimul. 2011;4:175–88.

  8. 8.

    Sabel BA, Fedorov AB, Naue N, Borrmann A, Herrmann C, Gall C. Non-invasive alternating current stimulation improves vision in optic neuropathy. Restor Neurol Neurosci. 2011;29:497–510.

    Google Scholar 

  9. 9.

    Bola M, Gall C, Moewes C, Fedorov A, Hinrichs H, Sabel BA. Brain functional connectivity network breakdown and restoration in blindness. Neurology. 2014;83:542–51.

    PubMed  Article  Google Scholar 

  10. 10.

    Susruta (1.300 BC). “Susruta Samhita”. Krishnadas Academy, Varanasi, India. 1998.

  11. 11.

    Flammer J, Konieczka K. The discovery of the Flammer syndrome: a historical and personal perspective. EPMA J. 2017;8:75–97.

    PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Konieczka K, Ritch R, Traverso CE, et al. Flammer syndrome. EPMA J. 2014;5:11.

    PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Fernald LD. Psychology: six perspectives. Thousand Oaks, CA: Sage Publications. 2008:12–5.

  14. 14.

    Folkman S. Stress: appraisal and coping. Encyclopedia of behavioral medicine. Springer. N Y. 2013:1913–5.

  15. 15.

    Shindler KS, Galetta SL, Volpe NJ. Functional visual loss. Curr Treat Options Neurol. 2004;6:67–73.

    PubMed  Article  Google Scholar 

  16. 16.

    Faiq MA, Dada R, Kumar A, et al. Brain: the potential diagnostic and therapeutic target for glaucoma. CNS Neurological Disorders Drug Targets. 2016;15:839–44.

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Gupta N, Yücel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18:110–4.

    PubMed  Article  Google Scholar 

  18. 18.

    Gupta N, Ang LC, De Tilly LN, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006;90:674–8.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  19. 19.

    Gupta N, Yücel YH. What changes can we expect in the brain of glaucoma patients? Surv Ophthalmol. 2007;52:S122–6.

    PubMed  Article  Google Scholar 

  20. 20.

    Wang J, Li T, Sabel BA, et al. Structural brain alterations in primary open angle glaucoma: a 3T MRI study. Sci Rep. 2016;6:18969.

  21. 21.

    Konieczka K, Choi HJ, Koch S, et al. Relationship between normal tension glaucoma and Flammer syndrome. EPMA J. 2017;8:111–7.

    PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Flammer J, Haefliger IO, Orgül S, et al. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8:212–9.

    PubMed  Article  CAS  Google Scholar 

  23. 23.

    Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007;52:S144–54.

    PubMed  Article  Google Scholar 

  24. 24.

    Bojinova RI, Konieczka K, Todorova MG. Unilateral loss of vision after spinal surgery in a patient with Flammer syndrome. Klin Monatsbl Augenheilkd. 2016;233:429–31.

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    Sabel BA. “Restoring Low Vision”. Amazon, 2016;241pp.

  26. 26.

    Rozanski C, Haythornthwaite JA, Dagnelie G, et al. Applying theories and interventions from behavioral medicine to understand and reduce visual field variability in patients with vision loss. Med Hypotheses. 2014;83:190–5.

    PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Olawoye O, Teng CC, Shabto U, et al. Visual recovery in a patient with total hyphema, neovascular glaucoma, long-standing retinal detachment and no light perception vision: a case report. J Med Case Rep. 2011;5:221.

    PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Cannon WB. Bodily changes in pain, hunger, fear and rage. Oxford: Appleton; 1929.

  29. 29.

    Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10:397–409.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  30. 30.

    Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. J Am Med Assoc. 2000;284:592–7.

    Article  CAS  Google Scholar 

  31. 31.

    Atzori M, Cuevas-Olguin R, Esquivel-Rendon E, et al. Locus ceruleus norepinephrine release: a central regulator of CNS spatio-temporal activation? Front Synaptic Neurosci. 2016;8:25.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  32. 32.

    Cohen S, Janicki-Deverts D, Doyle WJ, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci. 2012;109:5995–9.

    PubMed  Article  Google Scholar 

  33. 33.

    McKlveen JM, Myers B, Flak JN, et al. Role of prefrontal cortex glucocorticoid receptors in stress and emotion. Biol Psychiatry. 2013;74:672–9.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  34. 34.

    Lupien SJ, McEwen BS, Gunnar MR, et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10:434–45.

    PubMed  Article  CAS  Google Scholar 

  35. 35.

    Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.

    PubMed  Article  CAS  Google Scholar 

  36. 36.

    Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatr. 2003;160:1554–65.

    PubMed  Article  Google Scholar 

  37. 37.

    Roozendaal B, Koolhaas JM, Bohus B. Differential effect of lesioning of the central amygdala on the bradycardiac and behavioral response of the rat in relation to conditioned social and solitary stress. Behav Brain Res. 1990;41:39–48.

    PubMed  Article  CAS  Google Scholar 

  38. 38.

    Roozendaal B, Koolhaas JM, Bohus B. Central amygdala lesions affect behavioral and autonomic balance during stress in rats. Physiol Behav. 1991;50:777–81.

    PubMed  Article  CAS  Google Scholar 

  39. 39.

    Bhatnagar S, Vining C, Denski KAI. Regulation of chronic stress-induced changes in hypothalamic-pituitary-adrenal activity by the basolateral amygdala. Ann N Y Acad Sci. 2004;1032:315–9.

    PubMed  Article  CAS  Google Scholar 

  40. 40.

    Dayas CV, Buller KM, Day TA. Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala. Eur J Neurosci. 1999;11:2312–22.

    PubMed  Article  CAS  Google Scholar 

  41. 41.

    Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31.

    PubMed  Article  CAS  Google Scholar 

  42. 42.

    Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601–30.

    PubMed  PubMed Central  Article  Google Scholar 

  43. 43.

    Madrigal JLM, Moro MA, Lizasoain I, et al. Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide. Brain Res. 2002;938:87–91.

    PubMed  Article  CAS  Google Scholar 

  44. 44.

    O'Connor KA, Johnson JD, Hansen MK, et al. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003;991:123–32.

    PubMed  Article  CAS  Google Scholar 

  45. 45.

    Maes M. Major depression and activation of the inflammatory response system. flammerCytokines, stress, and depression. Springer US. 1999;25–46.

  46. 46.

    Leonard BE, Song C. Stress, depression, and the role of cytokines. Adv Exp Med Biol. 1999;461:251–65.

  47. 47.

    Torriglia A, Valamanesh F, Behar-Cohen F. On the retinal toxicity of intraocular glucocorticoids. Biochem Pharmacol. 2010;80:1878–86.

    PubMed  Article  CAS  Google Scholar 

  48. 48.

    Riccadonna M, Covi G, Pancera P, et al. Autonomic system activity and 24-hour blood pressure variations in subjects with normal-and high-tension glaucoma. J Glaucoma. 2003;12:156–63.

    PubMed  Article  Google Scholar 

  49. 49.

    Na KS, Lee NY, Park SH, et al. Autonomic dysfunction in normal tension glaucoma: the short-term heart rate variability analysis. J Glaucoma. 2010;19:377–81.

    PubMed  Article  Google Scholar 

  50. 50.

    Marc A, Stan C. Effect of physical and psychological stress on the course of primary open angle glaucoma. Oftalmologia (Bucharest, Romania: 1990). 2013;57:60–6.

    Google Scholar 

  51. 51.

    Stan C, Tirziu D, Lupaşcu S. A new risk factor in glaucoma? Oftalmologia (Bucharest, Romania: 1990). 2011;55:74–6.

  52. 52.

    Sommer A. Ocular hypertension and normal-tension glaucoma: time for banishment and burial. Arch Ophthalmol. 2011;129:785–7.

    PubMed  Article  Google Scholar 

  53. 53.

    Flammer J, Konieczka K, Bruno RM, et al. The eye and the heart. Eur Heart J. 2013;34:1270–8.

    PubMed  PubMed Central  Article  Google Scholar 

  54. 54.

    Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013;4:14.

    PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    Flammer J. Die glaukomatöse Optikusneuropathie: Ein Reperfusionsschaden. Klin Monatsbl Augenheilkd. 2001;218:290–1.

    PubMed  Article  CAS  Google Scholar 

  56. 56.

    Toda N, Nakanishi-Toda M. How mental stress affects endothelial function. Pflügers Archiv-Eur J Physiol. 2011;462:779–94.

    Article  CAS  Google Scholar 

  57. 57.

    Kurysheva NI, Tomilova IK, Kadykova EL, et al. Nitrogen oxide in the pathogenesis of glaucoma and cataract. Vestn oftalmol. 2001;117:34–7.

    PubMed  CAS  Google Scholar 

  58. 58.

    Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res. 2001;20:823–47.

    PubMed  Article  CAS  Google Scholar 

  59. 59.

    Kurysheva NI, Trubilin VN, Tsaregorodtseva MA, et al. Features autonomic nervous system cardiovascular system in patients with glaucoma normal pressure. Ophthalmology. 2012;9:44–8.

    Google Scholar 

  60. 60.

    Iwata M, Ota KT, Li XY, et al. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol Psychiatry. 2016;80:12–22.

    PubMed  Article  CAS  Google Scholar 

  61. 61.

    Shily BG. Psychophysiological stress, elevated intraocular pressure, and acute closed-angle glaucoma. Optom Vis Sci. 1987;64:866–70.

    Article  CAS  Google Scholar 

  62. 62.

    Bali SJ, Parmar T, Arora V, et al. Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol. Ophthalmologica. 2011;226:157–60.

    PubMed  Article  CAS  Google Scholar 

  63. 63.

    Severn P, Fraser S, Finch T, et al. Which quality of life score is best for glaucoma patients and why? BMC Ophthalmol. 2008;8:2.

    PubMed  PubMed Central  Article  Google Scholar 

  64. 64.

    De Leo D, Hickey PA, Meneghel G, et al. Blindness, fear of sight loss, and suicide. Psychosomatics. 1999;40:339–44.

    PubMed  Article  Google Scholar 

  65. 65.

    Nyman SR, Dibb B, Victor CR, et al. Emotional well-being and adjustment to vision loss in later life: a meta-synthesis of qualitative studies. Disabil Rehabil. 2012;34:971–81.

    PubMed  Article  Google Scholar 

  66. 66.

    Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008;14:224.

    PubMed  PubMed Central  CAS  Google Scholar 

  67. 67.

    Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359–93.

    PubMed  Article  Google Scholar 

  68. 68.

    Said SM, Albouaini K, Herold J, et al. Takotsubo syndrome from original description up to now. Medizinische Klinik (Munich, Germany: 1983). 2009;104:434–40.

    Article  Google Scholar 

  69. 69.

    Konieczka K, Koch S, Schoetzau A, et al. Increased prevalence of Flammer syndrome in patients with retinitis pigmentosa. Klin Monatsbl Augenheilkd. 2016;233:448–52.

    PubMed  Article  CAS  Google Scholar 

  70. 70.

    Fang L, Baertschi M, Mozaffarieh M. The effect of flammer-syndrome on retinal venous pressure. BMC Ophthalmol. 2014;14:121.

    PubMed  PubMed Central  Article  Google Scholar 

  71. 71.

    Flammer J, Konieczka K. Retinal venous pressure: the role of endothelin. EPMA J. 2015;6:21.

    PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Bojinova RI, Konieczka K, Meyer P, et al. The trilateral link between anaesthesia, perioperative visual loss and Flammer syndrome. BMC Anesthesiol. 2016;16:10.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  73. 73.

    Konieczka K, Koch S, Binggeli T, et al. Multiple sclerosis and primary vascular dysregulation (Flammer syndrome). EPMA J. 2016;7:1–5.

    Article  Google Scholar 

  74. 74.

    Bruce BB, Newman NJ. Functional visual loss. Neurol Clin. 2010;28:789–802.

    PubMed  PubMed Central  Article  Google Scholar 

  75. 75.

    Lim SA, Siatkowski RM, Farris BK. Functional visual loss in adults and children patient characteristics, management, and outcomes. Ophthalmology. 2015;112:1821–8.

    Article  Google Scholar 

  76. 76.

    Odberg T, Jakobsen JE, Hultgren SJ, et al. The impact of glaucoma on the quality of life of patients in Norway. Acta Ophthalmol. 2001;79:116–20.

    Article  CAS  Google Scholar 

  77. 77.

    Odberg T, Jakobsen JE, Hultgren SJ, et al. The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmol Scand. 2001;79:121–4.

    PubMed  Article  CAS  Google Scholar 

  78. 78.

    Hamelin N, Blatrix C, Brion F, et al. How patients react when glaucoma is diagnosed? J Fr Ophtalmol. 2002;25:795–8.

  79. 79.

    Bechetoille A, Arnould B, Bron A, et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL© 36-item questionnaire. Acta Ophthalmol. 2008;86:71–80.

    PubMed  Article  Google Scholar 

  80. 80.

    Bramley T, Peeples P, Walt JG, et al. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol. 2008;126:849–56.

    PubMed  Article  Google Scholar 

  81. 81.

    Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma. 2008;17:546–51.

    PubMed  Article  Google Scholar 

  82. 82.

    Kong X, Yan M, Sun X, et al. Anxiety and depression are more prevalent in primary angle closure glaucoma than in primary open-angle glaucoma. J Glaucoma. 2015;24:e57–63.

    PubMed  Article  Google Scholar 

  83. 83.

    Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol. 2012;96:821–5.

    PubMed  Article  Google Scholar 

  84. 84.

    Diniz-Filho A, Abe RY, Cho HJ, et al. Fast visual field progression is associated with depressive symptoms in patients with glaucoma. Ophthalmology. 2016;123:754–9.

    PubMed  PubMed Central  Article  Google Scholar 

  85. 85.

    Casten R, Edmonds S, Rovner B. The impact of depression in older adults with age-related macular degeneration. J Visual Impair Blindness. 2002;96:399–415.

  86. 86.

    Williams RA, Brody BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116:514–20.

    PubMed  Article  CAS  Google Scholar 

  87. 87.

    Wahl HW, Schilling O, Becker S. Age-related macular degeneration and change in psychological control: role of time since diagnosis and functional ability. J Gerontol Ser B Psychol Sci Soc Sci. 2007;62:P90–7.

    Article  Google Scholar 

  88. 88.

    Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795–809.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  89. 89.

    Strougo Z, Badoux A, Duchanel D. Psycho-affective problems associated with retinitis pigmentosa. J Fr Ophtalmol. 1996;20:111–6.

  90. 90.

    Bittner AK, Ibrahim MA, Haythomthwaite JA, et al. Vision test variability in retinitis pigmentosa and psychosocial factors. Optom Vis Sci. 2011;88:1496.

    PubMed  PubMed Central  Article  Google Scholar 

  91. 91.

    Hahm BJ, Shin YW, Shim EJ, et al. Depression and the vision-related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol. 2008;92:650–4.

    PubMed  Article  Google Scholar 

  92. 92.

    Angi M, Rupolo G, De Bertolini C, et al. Personality, psychophysical stress and myopia progression. Graefes Arch Clin Exp Ophthalmol. 1993;231:136–40.

    PubMed  Article  CAS  Google Scholar 

  93. 93.

    Avetisov ES, Gundorova RA, Shakarian AA, et al. Effects of acute psychogenic stress on the state of several functions of the visual analyzer. Vestn oftalmol. 1991;107:17–9.

    PubMed  CAS  Google Scholar 

  94. 94.

    Gawron VJ. Ocular accommodation, personality, and autonomic balance. Optom Vision Sci. 1983;60:630–9.

    Article  CAS  Google Scholar 

  95. 95.

    Li M, Gong L, Sun X, et al. Anxiety and depression in patients with dry eye syndrome. Curr Eye Res. 2011;36:1–7.

    PubMed  Article  Google Scholar 

  96. 96.

    Kaluza G, Maurer H. Stress and intraocular pressure in open angle glaucoma. Psychol Health. 1997;12:667–75.

    Article  Google Scholar 

  97. 97.

    Pagani M, Mazzuero G, Ferrari A, et al. Sympathovagal interaction during mental stress. A study using spectral analysis of heart rate variability in healthy control subjects and patients with a prior myocardial infarction. Circulation. 1991;83:II43–51.

    PubMed  CAS  Google Scholar 

  98. 98.

    Freeman EE, Lesk MR, Harasymowycz P, et al. Maladaptive coping strategies and glaucoma progression. Medicine. 2016;95:e4761.

  99. 99.

    Çakmak H, Altinyazar V, Yilmaz SG, et al. The temperament and character personality profile of the glaucoma patient. BMC Ophthalmol. 2015;15:125.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  100. 100.

    Bubella RM, Bubella DM, Cillino S. Type a behavior pattern: is it a risk factor for open-angle chronic glaucoma? J Glaucoma. 2014;23:199–201.

    PubMed  Article  Google Scholar 

  101. 101.

    Mabuchi F, Yoshimura K, Kashiwagi K, et al. Personality assessment based on the five-factor model of personality structure in patients with primary open-angle glaucoma. Jpn J Ophthalmol. 2005;49:31–5.

    PubMed  Article  Google Scholar 

  102. 102.

    Schinazi VR. Psychosocial implications of blindness and low-vision. CASA Working Papers 114, University College London, UK; 2007.

  103. 103.

    Carver CS, Connor-Smith J. Personality and coping. Annu Rev Psychol. 2010;61:679–704.

    PubMed  Article  Google Scholar 

  104. 104.

    Benn DT. The role of personality traits and coping strategies in late-life adaptation to vision loss. Dissertation, AAI9730084. ETD Collection for Fordham University; 1997.

  105. 105.

    Tolman J, Hill RD, Kleinschmidt JJ, et al. Psychosocial adaptation to visual impairment and its relationship to depressive affect in older adults with age-related macular degeneration. Gerontologist. 2005;45:747–53.

    PubMed  Article  Google Scholar 

  106. 106.

    von Arb M, Gompper B, Meyer AH, et al. Relationship between gender role, anger expression, thermal discomfort and sleep onset latency in women. Bio Psycho Soc Med. 2009;3:11.

    Google Scholar 

  107. 107.

    Kaluza G, Strempel I. Training in relaxation and visual imagery with patients who have open-angle glaucoma. Int J Rehabil Health. 1995;1:261–73.

    Article  Google Scholar 

  108. 108.

    Der Schultz-Zehden W. Einfluß psychotherapeutischer Maßnahmen auf die Behandlung des Primärglaukoms. Augenarzt. 1977;11:368–79.

    Google Scholar 

  109. 109.

    Brennan M, Cardinali G. The use of preexisting and novel coping strategies in adapting to age-related vision loss. Gerontologist. 2000;40:327–34.

  110. 110.

    Tang YY, Hölzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16:213–25.

    PubMed  Article  CAS  Google Scholar 

  111. 111.

    Pace TWW, Negi LT, Adame DD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology. 2009;34:87–98.

    PubMed  Article  CAS  Google Scholar 

  112. 112.

    Taneja DK. Yoga and health. Indian J Community Med. 2014;39:68.

  113. 113.

    Stahl JE, Dossett ML, LaJoie AS, et al. Relaxation response and resiliency training and its effect on healthcare resource utilization. PLoS One. 2015;10:e0140212.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  114. 114.

    Kruzliak P, Sabo J, Zulli A. Endothelial endoplasmic reticulum and nitrative stress in endothelial dysfunction in the atherogenic rabbit model. Acta Histochem. 2015;117:762–6.

    PubMed  Article  CAS  Google Scholar 

  115. 115.

    Flaten MA, Aslaksen PM, Finset A, et al. Cognitive and emotional factors in placebo analgesia. J Psychosom Res. 2006;61:81–9.

    PubMed  Article  Google Scholar 

  116. 116.

    Bushell WC. Longevity. Ann N Y Acad Sci. 2009;1172:20–7.

    PubMed  Article  Google Scholar 

  117. 117.

    Schneider RH, Grim CE, Rainforth MV, et al. Stress reduction in the secondary prevention of cardiovascular disease. Circulation: Cardiovasc Qual Outcomes. 2012;5:750–8.

    Google Scholar 

  118. 118.

    Kurth F, Cherbuin N, Luders E. Promising links between meditation and reduced (brain) aging: an attempt to bridge some gaps between the alleged fountain of youth and the youth of the field. Front Psychol. 2017;8

  119. 119.

    Backon J, Matamoros N, Ramirez M, et al. A functional vagotomy induced by unilateral forced right nostril breathing decreases intraocular pressure in open and closed angle glaucoma. Br J Ophthalmol. 1990;74:607–9.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  120. 120.

    Newberg AB, Iversen J. The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations. Med Hypotheses. 2003;61:282–91.

    PubMed  Article  CAS  Google Scholar 

  121. 121.

    Harte JL, Eifert GH, Smith R. The effects of running and meditation on beta-endorphin, corticotropin-releasing hormone and cortisol in plasma, and on mood. Biol Psychol. 1995;40:251–65.

    PubMed  Article  CAS  Google Scholar 

  122. 122.

    Jin J, Xu G, Yuan Z. Influence of the hypothalamic arcuate nucleus on intraocular pressure and the role of opioid peptides. PLoS One. 2014;9:e82315.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  123. 123.

    Sudsuang R, Chentanez V, Veluvan K. Effect of Buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiol Behav. 1991;50:543–8.

    PubMed  Article  CAS  Google Scholar 

  124. 124.

    Park J, Lyles RH, Bauer-Wu S. Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. American journal of physiology-regulatory. Integr Comp Physiol. 2014;307:R93–101.

    Article  CAS  Google Scholar 

  125. 125.

    Tanito M, Kaidzu S, Takai Y, et al. Correlation between systemic oxidative stress and intraocular pressure level. PLoS One. 2015;10:e0133582.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  126. 126.

    Coca-Prados M, Escribano J. New perspectives in aqueous humor secretion and in glaucoma: the ciliary body as a multifunctional neuroendocrine gland. Prog Retin Eye Res. 2007;26:239–62.

    PubMed  Article  CAS  Google Scholar 

  127. 127.

    Craigmyle NA. The beneficial effects of meditation: contribution of the anterior cingulate and locus coeruleus. Front Psychol. 2013;4:731.

    PubMed  PubMed Central  Article  Google Scholar 

  128. 128.

    Rosenkranz MA, Lutz A, Perlman DM, et al. Reduced stress and inflammatory responsiveness in experienced meditators compared to a matched healthy control group. Psychoneuroendocrinology. 2016;68:117–25.

    PubMed  PubMed Central  Article  Google Scholar 

  129. 129.

    Kemper KJ, Powell D, Helms CC, et al. Loving-kindness meditation’s effects on nitric oxide and perceived well-being: a pilot study in experienced and inexperienced meditators. Explore: J Sci Healing. 2015;11:32–9.

    Article  Google Scholar 

  130. 130.

    Behar-Cohen FF, Goureau O, D'Hermies F, et al. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci. 1996;37:1711–5.

    PubMed  CAS  Google Scholar 

  131. 131.

    Mohandas E. Neurobiology of spirituality. Mens Sana Monographs. 2008;6:63.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  132. 132.

    Newberg AB, Wintering N, Khalsa DS, et al. Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study. J Alzheimers Dis. 2010;20:517–26.

    PubMed  Article  Google Scholar 

  133. 133.

    Kaliman P, Álvarez-López MJ, Cosín-Tomás M, et al. Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators. Psychoneuroendocrinology. 2014;40:96–107.

    PubMed  Article  CAS  Google Scholar 

  134. 134.

    Tang YY, Ma Y, Wang J, et al. Short-term meditation training improves attention and self-regulation. Proc Natl Acad Sci. 2007;104:17152–6.

    PubMed  Article  Google Scholar 

  135. 135.

    Ospina MB, Bond K, Karkhaneh M, et al. Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep). 2007;155:1–263.

  136. 136.

    Wu SD, Lo PC. Inward-attention meditation increases parasympathetic activity: a study based on heart rate variability. Biomed Res. 2008;29:245–50.

    PubMed  Article  CAS  Google Scholar 

  137. 137.

    Grossman P, Niemann L, Schmidt S, et al. Mindfulness-based stress reduction and health benefits: a meta-analysis. J Psychosom Res. 2004;57:35–43.

    PubMed  Article  Google Scholar 

  138. 138.

    Netam R, Yadav RK, Khadgawat R, et al. Interleukin-6, vitamin D & diabetes risk-factors modified by a short-term yoga-based lifestyle intervention in overweight/obese individuals. Indian J Med Res. 2015;141:775.

    PubMed  PubMed Central  Article  Google Scholar 

  139. 139.

    Sharma P, Poojary G, Dwivedi SN, et al. Effect of yoga-based intervention in patients with inflammatory bowel disease. Int J Yoga Therapy. 2015;25:101–12.

    Article  Google Scholar 

  140. 140.

    Kemper KJ, Danhauer SC. Music as therapy. Southern Med J. 2005;98:282–8.

    PubMed  Article  Google Scholar 

  141. 141.

    Umemura M, Honda K. Influence of music on heart rate variability and comfort. J Hum Ergol. 1998;27:30–8.

    CAS  Google Scholar 

  142. 142.

    White JM. Effects of relaxing music on cardiac autonomic balance and anxiety after acute myocardial infarction. Am J Crit Care. 1999;8:220.

    PubMed  CAS  Google Scholar 

  143. 143.

    Pelletier CL. The effect of music on decreasing arousal due to stress: a meta-analysis. J Music Ther. 2004;41:192–214.

    PubMed  Article  Google Scholar 

  144. 144.

    Knight WEJ, Rickard NS. Relaxing music prevents stress-induced increases in subjective anxiety, systolic blood pressure, and heart rate in healthy males and females. J Music Ther. 2001;38:254–72.

    PubMed  Article  CAS  Google Scholar 

  145. 145.

    Mckee MG. Biofeedback: an overview in the context of heart-brain medicine. Cleve Clin J Med. 2008;75:S31.

    PubMed  Article  Google Scholar 

  146. 146.

    Amore FM, Paliotta S, Silvestri V, et al. Biofeedback stimulation in patients with age-related macular degeneration: comparison between 2 different methods. Can J Ophthalmology/J Can d'Ophtalmologie. 2013;48:431–7.

    Article  Google Scholar 

  147. 147.

    Moser DK, Dracup K, Woo MA, et al. Voluntary control of vascular tone by using skin-temperature biofeedback-relaxation in patients with advanced heart failure. Altern Ther Health Med. 1997;3:51–9.

    PubMed  CAS  Google Scholar 

  148. 148.

    Bernat SH, Wooldridge PJ, Marecki M, et al. Biofeedback-assisted relaxation to reduce stress in labor. J Obstet Gynecol Neonatal Nurs. 1992;21:295–303.

    PubMed  Article  CAS  Google Scholar 

  149. 149.

    Del Pozo JM, Gevirtz RN, Scher B, et al. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J. 2004;147:545.

    Article  Google Scholar 

  150. 150.

    Kaluza G, Strempel I. Effects of self-relaxation methods and visual imagery on IOP in patients with open-angle glaucoma. Ophthalmologica. 1995;209:122–8.

    PubMed  Article  CAS  Google Scholar 

  151. 151.

    Kaluza G, Strempel I, Maurer H. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients. J Behav Med. 1996;19:587–97.

    PubMed  Article  CAS  Google Scholar 

  152. 152.

    Bittner AK, Edwards L, George M. Coping strategies to manage stress related to vison loss and fluctuations in retinitis pigmentosa. Optom-J Am Optom Assoc. 2010;81:461–8.

    Article  Google Scholar 

  153. 153.

    Ben-Zur H, Debi Z. Optimism, social comparisons, and coping with vision loss in Israe. J Visual Impair Blindness. 2005;99:151.

    Google Scholar 

  154. 154.

    Dreer LE, Elliott TR, Fletcher DC, et al. Social problem-solving abilities and psychological adjustment of persons in low vision rehabilitation. Rehabil Psychol. 2005;50:232.

    Article  Google Scholar 

  155. 155.

    Garnefski N, Kraaij V, De Graaf M, et al. Psychological intervention targets for people with visual impairments: the importance of cognitive coping and goal adjustment. Disabil Rehabil. 2010;32:142–7.

    PubMed  Article  Google Scholar 

  156. 156.

    Bryan JL, Lu Q. Vision for improvement: expressive writing as an intervention for people with Stargardt's disease, a rare eye disease. Journal of Health Psychol. 2016;21:709–19.

    Article  Google Scholar 

  157. 157.

    Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vision Sci. 2001;78:335–42.

    Article  CAS  Google Scholar 

  158. 158.

    Lindenberg RE. Work with families in rehabilitation. Rehabil Couns Bull. 1977;21:(1):67–76.

  159. 159.

    Moore JE. Impact of family attitudes toward blindness/visual impairment on the rehabilitation process. J Visual Impair Blindness. 1984;78:100–6.

    Google Scholar 

  160. 160.

    Reinhardt JP. The importance of friendship and family support in adaptation to chronic vision impairment. J Gerontol Ser B Psychol Sci Soc Sci. 1996;51:P268–78.

    Article  CAS  Google Scholar 

  161. 161.

    Cimarolli VR, Boerner K. Social support and well-being in adults who are visually impaired. J Visual Impair Blindness. 2005;99:521.

    Google Scholar 

  162. 162.

    Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA J. 2016;7:23.

  163. 163.

    Zhang X, Bullard KMK, Cotch MF, et al. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. 2013;131:573–81.

    PubMed  PubMed Central  Article  Google Scholar 

  164. 164.

    Burmedi D, Becker S, Heyl V, et al. I Emotional and social consequences of age-related low vision: a narrative review Visual Impairment Research 2002;4:47–71.

  165. 165.

    Brennan M. Spirituality and psychosocial development in middle-age and older adults with vision loss. J Adult Dev. 2002;9:31–46.

    Article  Google Scholar 

  166. 166.

    Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol. 2002;120:1041–4.

    PubMed  Article  Google Scholar 

  167. 167.

    Wulsin LR, Jacobson AM, Rand LI. Psychosocial correlates of mild visual loss. Psychosom Med. 1991;53:109–17.

    PubMed  Article  CAS  Google Scholar 

  168. 168.

    Wahl HW, Kämmerer A, Holz F, et al. Psychosocial intervention for age-related macular degeneration: a pilot project. J Visual Impair Blindness. 2006;100:533.

    Google Scholar 

  169. 169.

    Packwood EA, Cruz OA, Rychwalski PJ, et al. The psychosocial effects of amblyopia study. J Am Assoc Pediatr Ophthalmol Strabismus. 1999;3:15–7.

    Article  CAS  Google Scholar 

  170. 170.

    Rees G, Tee HW, Marella M, et al. Vision-specific distress and depressive symptoms in people with vision impairment. Invest Ophthalmol Vis Sci. 2010;51:2891–6.

    PubMed  Article  Google Scholar 

  171. 171.

    Huurre TM, Aro HM. Psychosocial development among adolescents with visual impairment. Eur Child Adolesc Psychiatry. 1998;7:73–8.

    PubMed  Article  CAS  Google Scholar 

  172. 172.

    Yochim BP, Mueller AE, Kane KD, et al. Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma. J Glaucoma. 2012;21:250–4.

    PubMed  Article  Google Scholar 

  173. 173.

    Erb C, Batra A, Lietz A, et al. Psychological characteristics of patients with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1999;237:753–7.

    PubMed  Article  CAS  Google Scholar 

  174. 174.

    Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates. J Psychosom Res. 2013;75:75–82.

    PubMed  Article  Google Scholar 

  175. 175.

    Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–44.

    PubMed  Article  Google Scholar 

  176. 176.

    Piers G. Glaucoma: the ten-year report 1932–42 Chicago Institute for Psychoanalysis. Quoted in: Alexander F, French TM, eds. Studies in psychosomatic medicine. New York: Ronald; 1948.

    Google Scholar 

  177. 177.

    Pappa C, Hyphantis T, Pappa S, et al. Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. J Psychosom Res. 2006;61:609–17.

    PubMed  Article  Google Scholar 

  178. 178.

    Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults. Front Aging Neurosci. 2013;5:56.

    PubMed  PubMed Central  Article  Google Scholar 

  179. 179.

    Wang JJ, Mitchell P, Simpson JM, et al. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol. 2001;119:1186–90.

    PubMed  Article  CAS  Google Scholar 

  180. 180.

    Scott JA, Egan RA. Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol. 2003;135:670–5.

    PubMed  Article  Google Scholar 

  181. 181.

    Hallemani S, Kale M, Gholap M. Level of stress and coping strategies adopted by adolescents with visual impairment. International Journal of Science and Research. 2012;Paper ID:020141262.

  182. 182.

    Lee PP, Walt JW, Rosenblatt LC, et al. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144:901–7.e1.

    PubMed  Article  Google Scholar 

  183. 183.

    Rivera JL, Bell NP, Feldman RM. Risk factors for primary open angle glaucoma progression: what we know and what we need to know. Curr Opin Ophthalmol. 2008;19:102–6.

    PubMed  Article  Google Scholar 

  184. 184.

    Recupero SM, Contestabile MT, Taverniti L, et al. Open-angle glaucoma: variations in the intraocular pressure after visual field examination. J Glaucoma. 2003;12:114–8.

    PubMed  Article  Google Scholar 

  185. 185.

    Lee AJ, Saw SM, Gazzard G, et al. Intraocular pressure associations with refractive error and axial length in children. Br J Ophthalmol. 2004;88:5–7.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  186. 186.

    Sauerborn G, Schmitz M, Franzen U, et al. Stress and intraocular pressure in myopes. Psychol Health. 1992;6:61–8.

    Article  Google Scholar 

  187. 187.

    Grom E, Flazs O, Rozen AC. Personality of glaucoma patients as shown by psychological testing. Glaucoma. 1981;3:167–8.

    Google Scholar 

  188. 188.

    Amihai I, Kozhevnikov M. The influence of Buddhist meditation traditions on the autonomic system and attention. BioMed Research International. 2015.

  189. 189.

    Erb C, Thiel HJ, Flammer J. The psychology of the glaucoma patient. Curr Opin Ophthalmol. 1998;9:65–70.

    PubMed  Article  CAS  Google Scholar 

  190. 190.

    Kemeny ME. The psychobiology of stress. Curr Dir Psychol Sci. 2003;12:124–9.

    Article  Google Scholar 

  191. 191.

    Kloet E. Corticosteroids, stress, and aging. Ann N Y Acad Sci. 1992;663:357–71.

    PubMed  Article  Google Scholar 

  192. 192.

    Ritvanen T, Louhevaara V, Helin P, et al. Responses of the autonomic nervous system during periods of perceived high and low work stress in younger and older female teachers. Appl Ergon. 2006;37:311–8.

    PubMed  Article  Google Scholar 

  193. 193.

    Gherezghiher T, Hey JA, Koss MC. Parasympathetic nervous control of intraocular pressure. Exp Eye Res. 1990;50:457–62.

    PubMed  Article  CAS  Google Scholar 

  194. 194.

    Emmerich GM. Psychosomatische Symptome bei rein somatischen Krankheiten unter anderem am Beispiel eines chronischen Offenwinkelglaukoms. Klin Monatsbl Augenheilkd. 2010;227:638–45.

    PubMed  Article  CAS  Google Scholar 

  195. 195.

    Warrian KJ, Spaeth GL, Lankaranian D, et al. The effect of personality on measures of quality of life related to vision in glaucoma patients. Br J Ophthalmol. 2009;93:310–5.

    PubMed  Article  CAS  Google Scholar 

  196. 196.

    Beatty S. Non-organic visual loss. Postgrad Med J. 1999;75:201–7.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  197. 197.

    Werring DJ, Weston L, Bullmore ET, et al. Functional magnetic resonance imaging of the cerebral response to visual stimulation in medically unexplained visual loss. Psychol Med. 2004;34:583–9.

    PubMed  Article  CAS  Google Scholar 

  198. 198.

    Burggraaff MC, van Nispen RMA, Knol DL, et al. Randomized controlled trial on the effects of CCTV training on quality of life, depression, and adaptation to vision LossRCT on effects of CCTV training. Invest Ophthalmol Vis Sci. 2012;53:3645–52.

    PubMed  Article  Google Scholar 

  199. 199.

    Galvin JA, Benson H, Deckro GR, et al. The relaxation response: reducing stress and improving cognition in healthy aging adults. Complement Ther Clin Pract. 2006;12:186–91.

    PubMed  Article  Google Scholar 

  200. 200.

    Vøllestad J, Sivertsen B, Nielsen GH. Mindfulness-based stress reduction for patients with anxiety disorders: evaluation in a randomized controlled trial. Behav Res Ther. 2011;49:281–8.

    PubMed  Article  Google Scholar 

  201. 201.

    Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5:374–81.

    PubMed  Article  CAS  Google Scholar 

  202. 202.

    Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010;16:13–9.

    PubMed  Article  Google Scholar 

  203. 203.

    Sehgal M. Yoga for health. SENSE. 2011;1(1):322–27.

  204. 204.

    Haymes S, Guest D, Heyes A, et al. Mobility of people with retinitis pigmentosa as a function of vision and psychological variables. Optom Vision Sci. 1996;73:621–37.

    Article  CAS  Google Scholar 

  205. 205.

    McEwen BS. Stress and hippocampal plasticity. Annu Rev Neurosci. 1999;22:105–22.

    PubMed  Article  CAS  Google Scholar 

  206. 206.

    Gupta V, Dutta P, Mary OV, et al. Effect of glaucoma on the quality of life of young patients. Invest Ophthalmol Vis Sci. 2011;52:8433–7.

    PubMed  Article  Google Scholar 

  207. 207.

    Weitzman ED, Henkind P, Leitman M, et al. Correlatie 24-hour relationships between intraocular pressure and plasma cortisol in normal subjects and patients with glaucoma. Br J Ophthalmol. 1975;59:566.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  208. 208.

    Dampney RAL. Central mechanisms regulating coordinated cardiovascular and respiratory function during stress and arousal. Am J Phys Regul Integr Comp Phys. 2015;309:R429–43.

    CAS  Google Scholar 

  209. 209.

    Nordmann JP, Auzanneau N, Ricard S, et al. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75.

    PubMed  PubMed Central  Article  Google Scholar 

  210. 210.

    Keyworth C, Knopp J, Roughley K, et al. A mixed-methods pilot study of the acceptability and effectiveness of a brief meditation and mindfulness intervention for people with diabetes and coronary heart disease. Behav Med. 2014;40:53–64.

    PubMed  PubMed Central  Article  Google Scholar 

  211. 211.

    Manchanda SC, Madan K. Yoga and meditation in cardiovascular disease. Clin Res Cardiol. 2014;103:675–80.

    PubMed  Article  CAS  Google Scholar 

  212. 212.

    Hayman KJ, Kerse NM, La Grow SJ, et al. Depression in older people: visual impairment and subjective ratings of health. Optom Vision Sci. 2007;84:1024–30.

    Article  Google Scholar 

  213. 213.

    Méndez-Ulrich JL, Sanz A. Psycho-ophthalmology: contributions of health psychology to the assessment and treatment of glaucoma. Psychol Health. 2017;32:330–42.

    PubMed  Article  Google Scholar 

  214. 214.

    Niklewski G. Psychosomatische Erkrankungen des Auges: Eine Übersicht. Z Psychosom Med Psychoanal. 1982:300–16.

  215. 215.

    Grant P, Seiple W, Szlyk JP. Effect of depression on actual and perceived effects of reading rehabilitation for people with central vision loss. J Rehabil Res Dev. 2011;48:1101.

    PubMed  Article  Google Scholar 

  216. 216.

    Barris MC, Kaufman DI, Barberio D. Visual impairment in hysteria. Doc Ophthalmol. 1992;82:369–82.

    PubMed  Article  CAS  Google Scholar 

  217. 217.

    Khan AO. Severe psychogenic visual loss in a girl with siblings blinded from congenital glaucoma. JAm Assoc Pediatr Ophthalmol Strabismus. 2006;10:373–4.

    Article  Google Scholar 

  218. 218.

    Taich A, Crowe S, Kosmorsky GS, et al. Prevalence of psychosocial disturbances in children with nonorganic visual loss. J Am Assoc Pediatr Ophthalmol Strabismus. 2004;8:457–61.

    Article  Google Scholar 

  219. 219.

    Toldo I, Pinello L, Suppiej A, et al. Nonorganic (psychogenic) visual loss in children: a retrospective series. J Neuroophthalmol. 2010;30:26–30.

    PubMed  Article  Google Scholar 

  220. 220.

    Cohen SI, Hajioff J. Life events and the onset of acute closed-angle glaucoma. J Psychosom Res. 1972;16:335–41.

    PubMed  Article  CAS  Google Scholar 

  221. 221.

    Inman WS. Emotion and acute glaucoma. Lancet. 1929;214:1188–9.

    Article  Google Scholar 

  222. 222.

    Ripley HS, Wolff HG. Life situations, emotions, and glaucoma. Psychosom Med. 1950;12:215–24.

    PubMed  Article  CAS  Google Scholar 

  223. 223.

    Grignolo FM, Bongioanni C, Carenini BB. Variations of intraocular pressure induced by psychological stress. Klin Monatsbl Augenheilkd. 1977;170:562.

    PubMed  CAS  Google Scholar 

  224. 224.

    Weinstein P, Dobossy M. The psychosomatic factors in ophthalmology (author's transl). Klin Monatsbl Augenheilkd. 1975;166:537–9.

    PubMed  CAS  Google Scholar 

  225. 225.

    Dane ŞE, Kocer I, Demirel H, et al. Effect of acute submaximal exercise on intraocular pressure in athletes and sedentary subjects. Int J Neurosci. 2006;116:1223–30.

    PubMed  Article  Google Scholar 

  226. 226.

    Moschos MM. Physiology and psychology of vision and its disorders: a review. Medical hypothesis, discovery and innovation in. Ophthalmology. 2014;3:83.

    Google Scholar 

  227. 227.

    Beining G. Zur Psychotherapie des Glaukoms. Psychother Medizin Psychologie. 1951;1:59–63.

    Google Scholar 

  228. 228.

    Berger AS. The emotional factor in glaucoma: a review. Eye Ear Nose Throat Mon. 1960;39:166–70.

  229. 229.

    Böhringer HR, Müller C, Meerwein F. Psychiatry of primary glaucoma in relatively younger patients. KlinMonatsbl Augenheilkunde. 1953;123(3):283–302.

  230. 230.

    Flammer J. Kinderophthalmologie-Auge und Allgemeinerkrankungen. Auge und Psyche. 1999:215–24.

  231. 231.

    Schultz-Zehden W. Psychosomatische Einflüsse auf das Glaukom. Das autogene Training als unterstützende Therapie. Augenspiegel Heft. 1975;2:2–7.

    Google Scholar 

  232. 232.

    Abateneh A, Tesfaye M, Bekele S, et al. Vision loss and psychological distress among Ethiopians adults: a comparative cross-sectional study. PLoS One. 2013;8:e78335.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  233. 233.

    Thurston M, Thurston A, McLeod J. Socio-emotional effects of the transition from sight to blindness. Br J Vis Impair. 2010;28:90–112.

    Article  Google Scholar 

  234. 234.

    Srees S, Fear NT. Psychosocial impact of visual impairment and coping strategies in female ex-service personnel. J R Army Med Corps. 2016;162:129–33.

    Article  Google Scholar 

  235. 235.

    Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol. 2004;15:181–3.

    PubMed  Article  Google Scholar 

  236. 236.

    Nyman SR, Gosney MA, Victor CR. The psychosocial impact of vision loss on older people. Depression. 2010;2:98.

    Google Scholar 

  237. 237.

    Carrieri PB, Gentile S, Fusco R, et al. Mood disorders in patients with chronic simple glaucoma. Psychiatry Res. 1991;36:233–5.

    PubMed  Article  CAS  Google Scholar 

  238. 238.

    Bambara JK, Owsley C, Wadley V, et al. Family caregiver social problem-solving abilities and adjustment to caring for a relative with vision loss. Invest Ophthalmol Vis Sci. 2009;50:1585–92.

    PubMed  Article  Google Scholar 

  239. 239.

    Altangerel U, Spaeth GL, Rhee DJ. Visual function, disability, and psychological impact of glaucoma. Curr Opin Ophthalmol. 2003;14:100–5.

    PubMed  Article  Google Scholar 

  240. 240.

    Teoli DA, Smith MD, Leys MJ, et al. Visual function affects prosocial behaviors in older adults. Int Ophthalmol. 2016;36:45–54.

    PubMed  Article  Google Scholar 

  241. 241.

    Vu HTV, Keeffe JE, McCarty CA, et al. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol. 2005;89:360–3.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  242. 242.

    Keeffe J. Psychosocial impact of vision impairment. Elsevier. 2005;1282:167–73.

    Google Scholar 

  243. 243.

    Teitelman J, Copolillo A. Psychosocial issues in older adults’ adjustment to vision loss: findings from qualitative interviews and focus groups. Am J Occup Ther. 2005;59:409–17.

    PubMed  Article  Google Scholar 

  244. 244.

    Heine C, Browning CJ. Communication and psychosocial consequences of sensory loss in older adults: overview and rehabilitation directions. Disabil Rehabil. 2002;24:763–73.

    PubMed  Article  CAS  Google Scholar 

  245. 245.

    Datta P. Self-concept and vision impairment: a review. Br J Vis Impair. 2014;32:200–10.

    Article  Google Scholar 

  246. 246.

    Seybold D. The psychosocial impact of acquired vision loss—particularly related to rehabilitation involving orientation and mobility. Elsevier. 2005;1282:298–301.

    Google Scholar 

  247. 247.

    Scott IU, Smiddy WE, Schiffman J, et al. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol. 1999;128:54–62.

    PubMed  Article  CAS  Google Scholar 

  248. 248.

    Langelaan M, de Boer MR, van Nispen RMA, et al. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiol. 2007;14:119–26.

    PubMed  Article  Google Scholar 

  249. 249.

    Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med. 2005;67:89–97.

    PubMed  Article  Google Scholar 

  250. 250.

    Lim MC, Shiba DR, Clark IJ, et al. Personality type of the glaucoma patient. J Glaucoma. 2007;16:649–54.

    PubMed  Article  Google Scholar 

Download references


We thank Dr. Sundara Ram of the Mountain Top Clinic, Coonor, India, for pointing us to the Sanskrit source of Susruta [10].

Author information



Corresponding author

Correspondence to Bernhard A. Sabel.

Ethics declarations

Conflict of interest

B. Sabel is co-owner of a private medical practice ( where the two patients described in this paper were treated.

Ethical statement

For this type of study, formal consent is not required. We thank our patients for their consent to publish their case histories.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sabel, B.A., Wang, J., Cárdenas-Morales, L. et al. Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine. EPMA Journal 9, 133–160 (2018).

Download citation


  • Low vision
  • Psychology
  • Psychosomatic medicine
  • Relaxation
  • Restoration
  • Stress
  • Predictive
  • Preventive
  • Personalized medicine